Last week, Merck announced that "its experimental COVID pill reduced hospitalizations and deaths by 50 percent in people recently infected," according to NPR. Merck's next step is to ask for authorization for the pill in the U.S. Head over to NPR to learn more about the COVID-19 pill, how it works and what it might mean for our fight against COVID.